Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how.
作者信息
Ribera Josep-Maria
出版信息
Haematologica. 2011 Aug;96(8):1083-6. doi: 10.3324/haematol.2011.048348.
Abstract
摘要
相似文献
1
Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how.
Haematologica. 2011 Aug;96(8):1083-6. doi: 10.3324/haematol.2011.048348.
2
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica. 2011 Aug;96(8):1113-20. doi: 10.3324/haematol.2011.040261. Epub 2011 Apr 20.
3
Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia.
Haematologica. 2003 May;88(5):484-6.
4
Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.
Hematol Oncol Clin North Am. 2014 Dec;28(6):995-1009. doi: 10.1016/j.hoc.2014.08.008. Epub 2014 Oct 3.
5
Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Ann Hematol. 2019 Oct;98(10):2389-2398. doi: 10.1007/s00277-019-03771-2. Epub 2019 Aug 7.
6
[Chinese expert consensus of allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia (2022)].
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):793-801. doi: 10.3760/cma.j.issn.0253-2727.2022.10.001.
7
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
J Hematol Oncol. 2019 Oct 23;12(1):108. doi: 10.1186/s13045-019-0790-x.
8
The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia.
Curr Hematol Malig Rep. 2012 Jun;7(2):144-52. doi: 10.1007/s11899-012-0116-3.
9
Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Bone Marrow Transplant. 2008 Mar;41(5):455-64. doi: 10.1038/sj.bmt.1705889. Epub 2007 Oct 29.
10
Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation.
J Egypt Natl Canc Inst. 2020 Jun 15;32(1):28. doi: 10.1186/s43046-020-00042-4.
引用本文的文献
1
GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresis.
Front Immunol. 2024 Nov 18;15:1500177. doi: 10.3389/fimmu.2024.1500177. eCollection 2024.
2
Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre-transplant minimal residual disease on outcomes in high-risk acute lymphoblastic leukemia patients in complete remission.
Cancer Med. 2024 Jan;13(1):e6897. doi: 10.1002/cam4.6897. Epub 2024 Jan 2.
3
Transgenic HA-1-Specific CD8 T-Lymphocytes Selectively Target Leukemic Cells.
Cancers (Basel). 2023 Mar 3;15(5):1592. doi: 10.3390/cancers15051592.
4
A Comparison of Dexamethasone Plus Vincristine versus Standard Regimen in Induction Therapy of Adult Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplantation.
Int J Hematol Oncol Stem Cell Res. 2022 Jan 1;16(1):22-33. doi: 10.18502/ijhoscr.v16i1.8439.
5
Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell - Case Report.
Open Access Maced J Med Sci. 2017 May 9;5(3):340-343. doi: 10.3889/oamjms.2017.038. eCollection 2017 Jun 15.
6
Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
PLoS One. 2017 Apr 6;12(4):e0174760. doi: 10.1371/journal.pone.0174760. eCollection 2017.
7
A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature.
BMC Hematol. 2016 Jun 8;16:17. doi: 10.1186/s12878-016-0055-7. eCollection 2016.
8
[Outcomes of adults with Ph-negative B-cell acute lymphoblastic leukemia after autologous hematopoietic stem cell transplantation and the significance of minimal residual disease].
Zhonghua Xue Ye Xue Za Zhi. 2015 Jul;36(7):587-92. doi: 10.3760/cma.j.issn.0253-2727.2015.07.013.
9
Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
Chin Med J (Engl). 2015 Aug 5;128(15):2065-71. doi: 10.4103/0366-6999.161365.
10
Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL.
Bone Marrow Transplant. 2014 Feb;49(2):287-91. doi: 10.1038/bmt.2013.111. Epub 2013 Aug 12.
本文引用的文献
1
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
Blood. 2014 Feb 6;123(6):843-50. doi: 10.1182/blood-2013-09-529008. Epub 2013 Nov 25.
2
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.
J Clin Oncol. 2011 Jun 20;29(18):2493-8. doi: 10.1200/JCO.2010.32.7270. Epub 2011 May 16.
3
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica. 2011 Aug;96(8):1113-20. doi: 10.3324/haematol.2011.040261. Epub 2011 Apr 20.
4
Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives.
Cancer. 2011 Apr 15;117(8):1583-94. doi: 10.1002/cncr.25690. Epub 2010 Nov 8.
5
Reduced-intensity versus conventional myeloablative conditioning for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in complete remission.
Blood. 2011 Mar 31;117(13):3698-9. doi: 10.1182/blood-2011-01-329003.
6
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
Cancer. 2011 Sep 15;117(18):4238-46. doi: 10.1002/cncr.26033. Epub 2011 Mar 8.
7
Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Biol Blood Marrow Transplant. 2011 Jul;17(7):1093-7. doi: 10.1016/j.bbmt.2011.01.010. Epub 2011 Jan 28.
8
Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia.
Curr Opin Oncol. 2011 Mar;23(2):197-202. doi: 10.1097/CCO.0b013e328342b82a.
9
Adolescents and young adults with acute lymphoblastic leukemia.
Hematology Am Soc Hematol Educ Program. 2010;2010:21-9. doi: 10.1182/asheducation-2010.1.21.
10
Modern therapy of acute lymphoblastic leukemia.
J Clin Oncol. 2011 Feb 10;29(5):532-43. doi: 10.1200/JCO.2010.30.1382. Epub 2011 Jan 10.
Zotero 插件